Difference in survival between right- versus left-sided colorectal neuroendocrine neoplasms

Xu, Ge-han; Zou, Hua-wei; Grossman, Ashley B.

doi:10.1631/jzus.B1900210

Correspondence
Published: 15 October 2019

Difference in survival between right- versus left-sided colorectal neuroendocrine neoplasms

左右半结直肠神经内分泌肿瘤的生存差异研究

Journal of Zhejiang University-SCIENCE B volume 20, pages 933–939 (2019)Cite this article

64 Accesses
2 Citations
Metrics details

概要

目的

研究不同分期下左右半结直肠神经内分泌肿瘤 (NEN) 的生存差异。

创新点

左右半结直肠腺癌的生存差异已得到深入研究, 而结直肠NEN作为一罕见病理类型, 其左右半的生存差异尚缺乏研究。本研究旨在明确这一问题。

方法

选取 SEER 数据库中 1988~2014 年经病理确诊的结直肠 NEN 患者进行回顾性研究。多因素 Cox 回归分析比较左右半结直肠 NEN 的生存差异。

结论

相比于左半结直肠 NEN, 右半结肠 NEN 具有显著升高的死亡风险。而直肠与盲肠 NEN 是不同分期下左右半结直肠 NEN 生存差异的主要影响因素。

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

References

Benson AB III, Venook AP, Cederquist L, et al., 2017. Colon Cancer, Version 1.2017, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw, 15(3):370–398. https://doi.org/10.6004/jnccn.2017.0036
CAS Article Google Scholar
Cesar D, Zanatto RM, da Silva MV, et al., 2013. Colon and rectum neuroendocrine tumors: experience of the National Cancer Institute in Brazil. Arq Bras Cir Dig, 26(1): 36–39. https://doi.org/10.1590/S0102-67202013000100008
Article Google Scholar
Cives M, Strosberg JR, 2018. Gastroenteropancreatic neuro-endocrine tumors. CA Cancer J Clin, 68(6):471–487. https://doi.org/10.3322/caac.21493
Article Google Scholar
Clark OH, Benson AB III, Berlin JD, et al., 2009. NCCN clinical practice guidelines in oncology: neuroendocrine tumors. J Natl Compr Canc Netw, 7(7):712–747. https://doi.org/10.6004/jnccn.2009.0050
CAS Article Google Scholar
Dasari A, Shen C, Halperin D, et al., 2017. Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States. JAMA Oncol, 3(10):1335–1342. https://doi.org/10.1001/jamaoncol.2017.0589
Article Google Scholar
Garcia-Carbonero R, Sorbye H, Baudin E, et al., 2016. ENETS consensus guidelines for high-grade gastroenteropancre-atic neuroendocrine tumors and neuroendocrine carcinomas. Neuroendocrinology, 103(2):186–194. https://doi.org/10.1159/000443172
CAS Article Google Scholar
Gu Q, Lin YM, Cen L, et al., 2019. Endoscopic ultrasonog-raphy is useful in the diagnosis and treatment of rectal neuroendocrine neoplasms: a case series. J Zhejiang Univ-Sci B (Biomed & Biotechnol), 20(10):861–864. https://doi.org/10.1631/jzus.B1900168
Article Google Scholar
Jernvall P, Mäkinen MJ, Karttunen TJ, et al., 1999. Microsat-ellite instability: impact on cancer progression in proximal and distal colorectal cancers. Eur J Cancer, 35(2): 197–201. https://doi.org/10.1016/S0959-8049(98)00306-2
CAS Article Google Scholar
Meguid RA, Slidell MB, Wolfgang CL, et al., 2008. Is there a difference in survival between right- versus left-sided colon cancers? Ann Surg Oncol, 15(9):2388–2394. https://doi.org/10.1245/s10434-008-0015-y
Article Google Scholar
Mik M, Berut M, Dziki L, et al., 2017. Right- and left-sided colon cancer—clinical and pathological differences of the disease entity in one organ. Arch Med Sci, 13(1):157–162. https://doi.org/10.5114/aoms.2016.58596
Article Google Scholar
Mitry E, Baudin E, Ducreux M, et al., 1999. Treatment of poorly differentiated neuroendocrine tumours with etopo-side and cisplatin. Br J Cancer, 81(8):1351–1355. https://doi.org/10.1038/sj.bjc.6690325
CAS Article Google Scholar
Modlin IM, Lye KD, Kidd M, 2003. A 5-decade analysis of 13,715 carcinoid tumors. Cancer, 97(4):934–959. https://doi.org/10.1002/cncr.11105
Article Google Scholar
Patta A, Fakih M, 2011. First-line cisplatin plus etoposide in high-grade metastatic neuroendocrine tumors of colon and rectum (MCRC NET): review of 8 cases. Anticancer Res, 31(3):975–978.
PubMed Google Scholar
Popat S, Hubner R, Houlston RS, 2005. Systematic review of microsatellite instability and colorectal cancer prognosis. J Clin Oncol, 23(3):609–618. https://doi.org/10.1200/JCO.2005.01.086
CAS Article Google Scholar
Portale TR, Branca A, Pesce A, et al., 2012. Neuroendocrine carcinoma of colon and rectum: a rare neoplasia with a poor prognosis. Minerva Chir, 67(3):283–284.
CAS PubMed Google Scholar
Price TJ, Beeke C, Ullah S, et al., 2015. Does the primary site of colorectal cancer impact outcomes for patients with metastatic disease? Cancer, 121(6):830–835. https://doi.org/10.1002/cncr.29129
Article Google Scholar
Sahnane N, Furlan D, Monti M, et al., 2015. Microsatellite unstable gastrointestinal neuroendocrine carcinomas: a new clinicopathologic entity. Endocr Relat Cancer, 22(1): 35-45. https://doi.org/10.1530/ERC-14-0410
Google Scholar
Snaebjornsson P, Jonasson L, Jonsson T, et al., 2010. Colon cancer in Iceland—a nationwide comparative study on various pathology parameters with respect to right and left tumor location and patients age. Int J Cancer, 127(11): 2645–2653. https://doi.org/10.1002/ijc.25258
CAS Article Google Scholar
Starzyńska T, Deptała A, Królicki L, et al., 2013. Colorectal neuroendocrine neoplasms—management guidelines (recommended by the Polish Network of Neuroendocrine Tumours). Endokrynol Pol, 64(6):494–504. https://doi.org/10.5603/EP.2013.0032
Article Google Scholar
Starzyńska T, Londzin-Olesik M, Bałdys-Waligórska A, et al., 2017. Colorectal neuroendocrine neoplasms—management guidelines (recommended by the Polish Network of Neu-roendocrine Tumours). Endokrynol Pol, 68(2):250–260. https://doi.org/10.5603/EP.2017.0019
Article Google Scholar
Yao JC, Hassan MM, Phan A, et al., 2008. One hundred years after “carcinoid”: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol, 26(18):3063–3072 https://doi.org/10.1200/JCO.2007.15.4377
Article Google Scholar

Download references

Author information

Affiliations

The Second Clinical College of China Medical University, Shenyang, 110004, China
Ge-han Xu
1st Department of Oncology, Shengjing Hospital Affiliated to China Medical University, Shenyang, 110022, China
Hua-wei Zou
NET Unit, ENETS Centre of Excellence, Royal Free Hospital, London, NW3 2QG, UK
Ashley B. Grossman

Authors

Ge-han Xu
View author publications
You can also search for this author in PubMed Google Scholar
Hua-wei Zou
View author publications
You can also search for this author in PubMed Google Scholar
Ashley B. Grossman
View author publications
You can also search for this author in PubMed Google Scholar

Contributions

Ge-han XU collected and analyzed the data, and wrote the manuscript. Hua-wei ZOU and Ashley B. GROSSMAN contributed to the study design, data analysis, writing and editing of the manuscript. All authors have read and approved the final manuscript and, therefore, had full access to all the data in the study and take responsibility for the integrity and security of the data.

Corresponding author

Correspondence to Hua-wei Zou.

Ethics declarations

Ge-han XU, Hua-wei ZOU, and Ashley B. GROSSMAN declare that they have no conflict of interest.

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

Project supported by the Beijing Medical and Health Foundation (No. YWJKQ4008), China

Electronic supplementary material